Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Applied Imaging Corp. (NasdaqNM:AICX)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Msgs | Insider | Financials
Recent Events
Aug  1Conference call: Applied Imaging Earnings (Q2 2001)
Location
2380 Walsh Avenue, Building B
Santa Clara, CA 95051
Phone: (408) 562-0250
Fax: (408) 562-0264
Email: bhotchkies@aicorp.com
Employees (last reported count): 103
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Medical Equipment & Supplies
Company Websites
 ·Home Page
 ·Yahoo! Category

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 39%
·Over the last 6 months:
 · one insider buy; 20.0K shares (0.2% of insider shares)
 · 23 insider sells; 2.22M shares
  (27.4% of insider shares)
·Institutional: 35% (58% of float)
(16 institutions)
·Net Inst. Buying: 32.0K shares (+0.59%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Applied Imaging Corp. is a provider of automated cytogenetic instrument systems. The Company's products are sold worldwide through a direct sales force, third-party distributors and independent sales representatives. The Company sells its products to government and private clinical laboratories, research institutions, universities, and pharmaceutical companies located in the United States, Canada, Europe, and the Pacific Rim. The Company also markets imaging systems designed for use in plant and animal genetic research programs. In addition, the Company recently introduced and has received clearance from the Food and Drug Administration for a clinical system to detect micrometastatic cancer cells in bone marrow from cancer patients. This system and its research capabilities allows physicians to better determine the initial staging of cancer cases, to detect disease recurrence earlier than is currently possible and to genetically characterize cancer cells.
More from Market Guide: Expanded Business Description

Financial Summary
Applied Imaging designs, develops, manufactures and markets automated image analysis systems used by cytogenetic laboratories for prenatal, cancer and other genetic testing applications. For the six months ended 6/30/01, revenues rose 5% to $8.5 million. Net loss rose 44% to $2.6 million. Revenues reflect increased service contracts and North America sales. Higher loss reflects increased sales and marketing expenses due to higher MDS sales and support personnel.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Pay

Jack Goldstein, Ph. D., 53
Chairman
$363K
Carl Hull, 42
Pres, CEO, Director
238K
Barry Hotchkies, 55
CFO, VP-Fin.
128K
Padraig O'Kelly, 42
VP-Operations
187K
Daniel Bowman, 42
VP--Worldwide Sales and Marketing
273K
Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc..
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqNM:AICXAs of 31-Aug-2001
Price and Volume
52-Week Low
on 12-Mar-2001
$1.563
Recent Price$2.05 
52-Week High
on 6-Sep-2000
$7.203
Beta-0.25 
Daily Volume (3-month avg)36.5K
Daily Volume (10-day avg)10.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y]
52-Week Change-64.3%
52-Week Change
relative to S&P500
-52.2%
Share-Related Items
Market Capitalization$31.2M
Shares Outstanding15.2M
Float9.30M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)$0.46 
Earnings (ttm)-$0.34 
Earnings (mrq)-$0.06 
Sales (ttm)$1.18 
Cash (mrq)$0.18 
Valuation Ratios
Price/Book (mrq)4.50 
Price/EarningsN/A 
Price/Sales (ttm)1.74 
Income Statements
Sales (ttm)$17.1M
EBITDA (ttm)-$4.68M
Income available to common (ttm)-$5.00M
Profitability
Profit Margin (ttm)-29.2%
Operating Margin (ttm)-29.1%
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)-29.03%
Return on Equity (ttm)-63.56%
Financial Strength
Current Ratio (mrq)1.49 
Debt/Equity (mrq)0.31 
Total Cash (mrq)$2.71M
Short Interest
As of 8-Aug-2001
Shares Short2,000 
Percent of Float0.0%
Shares Short
(Prior Month)
0 
Short Ratio0.07 
Daily Volume27.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.